Trial intelligence / Profile preview

Ketamine vs Fentanyl in Septic Shock

NCT05957302Completed

Sponsor
Cairo University
Start
Aug 2023
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of ketamine in septic shock (2 arms), sponsored by Cairo University. Primary endpoint: 6-minutes Percentage Change in Cardiac Output. Started Aug 2023; status: completed.

02

Drugs

ketamine
03

Conditions

septic shock

Beyond the preview

Go deeper on NCT05957302.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05957302.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call